{"nct_id":"NCT01723072","title":"Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy","status":"COMPLETED","status_verified_date":"2020-08","start_date":"2013-01-23","start_date_type":"ACTUAL","primary_completion_date":"2014-05-09","primary_completion_date_type":"ACTUAL","completion_date":"2014-05-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}